Cargando…
Promoter Hypomethylation Is Responsible for Upregulated Expression of HAI-1 in Hepatocellular Carcinoma
An upregulated expression of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in hepatocellular carcinomas (HCC) associates with poor prognosis, but the underlying mechanism for expression regulation has not been elucidated. HAI-1 was expressed in HCC cell line Hep3B cells at a high level...
Autores principales: | Du, Xiaoxiao, Wu, Lingyan, Ur Rahman, Muhammad Saif, Teng, Xiaodong, Teng, Lisong, Ye, Jingjia, Cao, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735181/ https://www.ncbi.nlm.nih.gov/pubmed/31558918 http://dx.doi.org/10.1155/2019/9175215 |
Ejemplares similares
-
Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells
por: Mao, Chenyu, et al.
Publicado: (2015) -
Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma
por: Ahn, Hye Ri, et al.
Publicado: (2022) -
Hypomethylation status of miR-657 promoter region as biomarker for diagnosis of hepatocellular carcinoma: a retrospective study
por: Shi, Zhaoqi, et al.
Publicado: (2022) -
Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma
por: Liu, Hui-Hui, et al.
Publicado: (2020) -
Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma
por: Cho, M, et al.
Publicado: (2001)